DekaBank Deutsche Girozentrale
ADMS

DekaBank Deutsche Girozentrale’s Adamas Pharmaceuticals ADMS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,400
Closed -$91K – 1162
2019
Q2 		$91K Buy
15,400
+6,000
+64% +$34.5K ﹤0.01% 1091
2019
Q1 		$216K Buy
9,400
+1,700
+22% +$15.3K ﹤0.01% 1029
2018
Q4 		$65K Sell
7,700
-1,700
-18% -$22.1K ﹤0.01% 1116
2018
Q3 		$216K Sell
9,400
-200
-2% -$4.7K ﹤0.01% 1051
2018
Q2 		$242K Hold
9,600
– – ﹤0.01% 1022
2018
Q1 		$227K Buy
+9,600
New +$303K ﹤0.01% 977
2016
Q2 		– Sell
-10,800
Closed -$152K – 1068
2016
Q1 		$152K Buy
+10,800
New +$182K ﹤0.01% 891

Other funds holding ADMS

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ADMS Position: Q3 2019 in Review

DekaBank Deutsche Girozentrale sold out of Adamas Pharmaceuticals (ADMS) in Q3 2019, closing a stake of 15,400 shares — an estimated $91K sold.

DekaBank Deutsche Girozentrale first reported a position in ADMS in Q1 2016 and held it in 7 quarters. The position peaked at $242K in Q2 2018. 87 funds tracked by Wall St. Rank hold ADMS as of Q3 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Adamas Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 15,400 Adamas Pharmaceuticals shares in Q3 2019, an estimated $91K.
  • DekaBank Deutsche Girozentrale first reported a position in Adamas Pharmaceuticals in Q1 2016 and held it in 7 quarters.
  • DekaBank Deutsche Girozentrale's Adamas Pharmaceuticals position peaked at $242K in Q2 2018.
  • 87 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.